Journal article icon

Journal article

Predictable threats to public health through delaying universal access to innovative medicines for Hepatitis C: A pharmaceutical standpoint

Abstract:

The new interferon-free direct-acting antiviral (DAAs) treatment combinations have with the potential to provide a cure for Hepatitis C Virus patients and stop the pandemic, but their high prices keep treatment out of reach for most patients in Low- and Middle-Income countries, and the access strategies voluntarily put in place by some pharmaceutical companies remain insufficient to provide treatment to all those in need. This creates room for unregulated markets and pushes desperate patients...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed
Version:
Publisher's version

Actions


Access Document


Files:
Publisher copy:
10.1111/tmi.12784

Authors


Expand authors...
More from this funder
Funding agency for:
Newton, P
Publisher:
John Wiley & Sons Ltd Publisher's website
Journal:
Tropical Medicine and International Health Journal website
Volume:
21
Issue:
12
Pages:
1490–1495
Publication date:
2016-09-27
Acceptance date:
2016-09-18
DOI:
EISSN:
1365-3156
ISSN:
1360-2276
Pubs id:
pubs:648248
URN:
uri:c4763dce-2a60-406a-98eb-165ccfc310cc
UUID:
uuid:c4763dce-2a60-406a-98eb-165ccfc310cc
Local pid:
pubs:648248
Paper number:
12

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP